Cargando…

Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study

Diabetic kidney disease (DKD) is a highly heterogenous disease, including the proteinuric and the nonproteinuric pattern. Oxidized low-density lipoprotein (ox-LDL) is progressively increased in DKD and causes direct damage to kidney tubular epithelial cells through a mechanism similar to that underl...

Descripción completa

Detalles Bibliográficos
Autores principales: Roumeliotis, Stefanos, Roumeliotis, Athanasios, Georgianos, Panagiotis I., Stamou, Aikaterini, Manolopoulos, Vangelis G., Panagoutsos, Stylianos, Liakopoulos, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548137/
https://www.ncbi.nlm.nih.gov/pubmed/34712380
http://dx.doi.org/10.1155/2021/2968869
_version_ 1784590509211123712
author Roumeliotis, Stefanos
Roumeliotis, Athanasios
Georgianos, Panagiotis I.
Stamou, Aikaterini
Manolopoulos, Vangelis G.
Panagoutsos, Stylianos
Liakopoulos, Vassilios
author_facet Roumeliotis, Stefanos
Roumeliotis, Athanasios
Georgianos, Panagiotis I.
Stamou, Aikaterini
Manolopoulos, Vangelis G.
Panagoutsos, Stylianos
Liakopoulos, Vassilios
author_sort Roumeliotis, Stefanos
collection PubMed
description Diabetic kidney disease (DKD) is a highly heterogenous disease, including the proteinuric and the nonproteinuric pattern. Oxidized low-density lipoprotein (ox-LDL) is progressively increased in DKD and causes direct damage to kidney tubular epithelial cells through a mechanism similar to that underlying the deleterious effect of lipid peroxides in the vascular endothelium. We aimed to examine the association between plasma ox-LDL cholesterol and clinical endpoints in DKD patients. Ninety-one patients with established proteinuric DKD and diabetic retinopathy were enrolled and prospectively followed for 10 years or the occurrence of death, or at least 30% decline in eGFR, or progression to end-stage kidney disease (ESKD) requiring renal replacement therapy (primary outcome). At the end of the study, both eGFR and proteinuria were reassessed. Secondary outcomes of the study were the percentage change in eGFR and proteinuria over time for each patient. At baseline, patients were divided into 2 groups according to the median ox-LDL value (i.e., below or equal and above 66.22 U/L). Both Kaplan-Meier curves (p = 0.001, log-rank test) and univariate Cox regression analysis showed that high ox-LDL was associated with the primary outcome (HR = 3.42, 95%CI = 1.55 − 7.56, p = 0.002). After adjustment for various well-known cofounders, multivariate Cox analysis showed that the association between increased circulating ox-LDL levels and the composite kidney endpoint remained significant (HR = 2.87, 95%CI = 1.14–7.20, p = 0.025). Regarding the secondary outcome of eGFR decline, the assessment of areas under the curves (AUC) showed that ox-LDL outperformed several cofounding factors (AUC 71%, 95%CI = 0.59 − 0.83, p = 0.001) and had better accuracy to predict deterioration of eGFR over time than baseline proteinuria (AUC 67%, 95%CI = 0.54 − 0.79, p = 0.014). Increased ox-LDL might be associated with disease progression in proteinuric DKD.
format Online
Article
Text
id pubmed-8548137
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85481372021-10-27 Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study Roumeliotis, Stefanos Roumeliotis, Athanasios Georgianos, Panagiotis I. Stamou, Aikaterini Manolopoulos, Vangelis G. Panagoutsos, Stylianos Liakopoulos, Vassilios Oxid Med Cell Longev Research Article Diabetic kidney disease (DKD) is a highly heterogenous disease, including the proteinuric and the nonproteinuric pattern. Oxidized low-density lipoprotein (ox-LDL) is progressively increased in DKD and causes direct damage to kidney tubular epithelial cells through a mechanism similar to that underlying the deleterious effect of lipid peroxides in the vascular endothelium. We aimed to examine the association between plasma ox-LDL cholesterol and clinical endpoints in DKD patients. Ninety-one patients with established proteinuric DKD and diabetic retinopathy were enrolled and prospectively followed for 10 years or the occurrence of death, or at least 30% decline in eGFR, or progression to end-stage kidney disease (ESKD) requiring renal replacement therapy (primary outcome). At the end of the study, both eGFR and proteinuria were reassessed. Secondary outcomes of the study were the percentage change in eGFR and proteinuria over time for each patient. At baseline, patients were divided into 2 groups according to the median ox-LDL value (i.e., below or equal and above 66.22 U/L). Both Kaplan-Meier curves (p = 0.001, log-rank test) and univariate Cox regression analysis showed that high ox-LDL was associated with the primary outcome (HR = 3.42, 95%CI = 1.55 − 7.56, p = 0.002). After adjustment for various well-known cofounders, multivariate Cox analysis showed that the association between increased circulating ox-LDL levels and the composite kidney endpoint remained significant (HR = 2.87, 95%CI = 1.14–7.20, p = 0.025). Regarding the secondary outcome of eGFR decline, the assessment of areas under the curves (AUC) showed that ox-LDL outperformed several cofounding factors (AUC 71%, 95%CI = 0.59 − 0.83, p = 0.001) and had better accuracy to predict deterioration of eGFR over time than baseline proteinuria (AUC 67%, 95%CI = 0.54 − 0.79, p = 0.014). Increased ox-LDL might be associated with disease progression in proteinuric DKD. Hindawi 2021-10-19 /pmc/articles/PMC8548137/ /pubmed/34712380 http://dx.doi.org/10.1155/2021/2968869 Text en Copyright © 2021 Stefanos Roumeliotis et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Roumeliotis, Stefanos
Roumeliotis, Athanasios
Georgianos, Panagiotis I.
Stamou, Aikaterini
Manolopoulos, Vangelis G.
Panagoutsos, Stylianos
Liakopoulos, Vassilios
Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study
title Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study
title_full Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study
title_fullStr Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study
title_full_unstemmed Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study
title_short Oxidized LDL Is Associated with eGFR Decline in Proteinuric Diabetic Kidney Disease: A Cohort Study
title_sort oxidized ldl is associated with egfr decline in proteinuric diabetic kidney disease: a cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548137/
https://www.ncbi.nlm.nih.gov/pubmed/34712380
http://dx.doi.org/10.1155/2021/2968869
work_keys_str_mv AT roumeliotisstefanos oxidizedldlisassociatedwithegfrdeclineinproteinuricdiabetickidneydiseaseacohortstudy
AT roumeliotisathanasios oxidizedldlisassociatedwithegfrdeclineinproteinuricdiabetickidneydiseaseacohortstudy
AT georgianospanagiotisi oxidizedldlisassociatedwithegfrdeclineinproteinuricdiabetickidneydiseaseacohortstudy
AT stamouaikaterini oxidizedldlisassociatedwithegfrdeclineinproteinuricdiabetickidneydiseaseacohortstudy
AT manolopoulosvangelisg oxidizedldlisassociatedwithegfrdeclineinproteinuricdiabetickidneydiseaseacohortstudy
AT panagoutsosstylianos oxidizedldlisassociatedwithegfrdeclineinproteinuricdiabetickidneydiseaseacohortstudy
AT liakopoulosvassilios oxidizedldlisassociatedwithegfrdeclineinproteinuricdiabetickidneydiseaseacohortstudy